What is the long-term trend for Aurinia Pharmaceuticals's software and technology licenses, net?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's software and technology licenses, net has grown at a -17.7% compound annual growth rate (CAGR), from $247K to $93K.

Aurinia Pharmaceuticals AUPH Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Rogers CorporationROG

——

Vera TherapeuticsVERA

——

ANI PharmaceuticalsANIP

——

Ultragenyx PharmaceuticalRARE

——

Agios PharmaceuticalsAGIO

——

Kiniksa Pharmaceuticals International, plcKNSA

——

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's software and technology licenses, net?: Aurinia Pharmaceuticals (AUPH) reported software and technology licenses, net of $93K in Q1 2026.
How has Aurinia Pharmaceuticals's software and technology licenses, net changed year-over-year?: Aurinia Pharmaceuticals's software and technology licenses, net decreased by 88.7% year-over-year, from $823K to $93K.
What is the long-term trend for Aurinia Pharmaceuticals's software and technology licenses, net?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's software and technology licenses, net has grown at a -17.7% compound annual growth rate (CAGR), from $247K to $93K.